Diagnostic criteria for primary immunodeficiencies. [Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)]. Clin Immunol 1999; 93:190–197., , .
Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002; 109:1001–1004., , .
Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency. Allergy 2005; 60:385–390., , , .
et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011; 31:315–322., ,
et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112:277–286., ,
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies. Clin Immunol 2011; 139:133–141., , , .
et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol 2012; 130:1197–8.e9., ,
Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010; 125:1354–1360.e4., , , , , .
et al. Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels. J Clin Immunol 2010; 30:602–606., ,
A thoretical model of gamma-globulin catabolism. Nature 1964; 203:1352–1354., , .
An Fc receptor structurally related to MHC class I antigens. Nature 1989; 337:184–187., .
et al. Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 2010; 30:777–789., ,
Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model. Clin Immunol 2007; 122:146–155., , , .
et al. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol. 2009; 31:223–236., ,
et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 2002; 196:303–310., ,
Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism. J Immunol 2007; 179:4580–4588., , , .
A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter. Immunology 2006; 119:83–89., , , , , .
et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis 2008; 46:1547–1554., ,
Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia. Pediatr Infect Dis J 1988; 7:S92–96., .
et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001; 135:165–174., ,
Subcutaneous administration of IgG. Immunol Allergy Clin North Am 2008; 28:779–802..
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol 2010; 137:21–30., , , .
Higher doses of subcutaneous IgG reduce resource utilization in patients with primary immunodeficiency. J Clin Immunol 2012; 32:281–289., , , , , .
How I treat common variable immune deficiency. Blood 2010; 116:7–15..
Disorders of immunoglobulin metabolism. N Engl J Med 1969; 281:1170–1177..
Metabolism of gamma-SS globulin in secondary hypogammaglobulinemia. Am J Med 1963; 35:708–714..
Distribution and catabolism of IVIg preparations in immunodeficient patients. In: Imbach P , ed. Immunotherapy with intravenous immunoglobulins. London: Academic Press, 1991:37–44..
Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency. Clin Exp Immunol 2009; 157 (Suppl. 1):12–16..
et al. Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency. Clin Immunol 2010; 136:419–425., ,